+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-02-09Number of Pages: 238

Pulmonary Drug Delivery Devices Market (Product Type - Dry Powder Inhalers, Metered Dose Inhalers and Nebulizers; Application - Asthma, COPD, and Cystic Fibrosis; Distribution Channel - Retail Pharmacies, Hospital Pharmacies, and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Pulmonary Drug Delivery Devices Market: Snapshot

The global market for pulmonary drug devices has gained substantially over the last few years and, with the alarming rise in the air pollution leading to the increased incidence rate of respiratory disorders, it is likely to maintain its growth at a high pace in the years to come. The increasing number of smokers across the world is also adding to the rising pool of the patients suffering from chronic obstructive pulmonary diseases (COPD), consequently benefitting the worldwide pulmonary drug delivery devices market considerably.

Going forward, the market is expected to gain significant momentum over the next few years due to the increasing research and development activities in asthma and COPD treatments. However, various regulatory hurdles and the patent expiry of blockbuster drugs may restrict the growth of this market to some extent in the near future.

pulmonary drug delivery devices market

The global market for pulmonary drug devices presented an opportunity worth US$32.2 bn in 2015. Propagating at a CAGR of 3.30% during the period from 2016 to 2024, the market is likely to attain a value of US$43.05 bn by the end of 2024.

North America and Europe to Continue to Lead Global Pulmonary Drug Delivery Devices Market

Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa are the main regional markets for pulmonary drug delivery devices. Of these, North America has acquired the top position and is followed closely by Europe. The increasing prevalence of COPD is the key factor behind the growth of these regional markets. Analysts expect both the markets to retain their position over the forthcoming years, thanks to the technological advancements in pulmonary drug delivery devices. The U.S. and Canada have surfaced as the key domestic markets in North America, whereas, the Europe market for pulmonary drug delivery devices is led by Germany.

On the other hand, the pulmonary drug delivery devices market in Asia Pacific, Latin America, and the Middle East and Africa are likely to present great opportunities to manufacturers in the near future due to the high incidence rate of respiratory disorders. The growing awareness among consumers and their increasing disposable income are also projected to drive these markets over the next few years.

Demand for Pulmonary Drug Delivery Devices to Remain High among Asthma Patients

Pulmonary drug delivery devices find a widespread application in the treatment of asthma, COPD, and cystic fibrosis. Among these, the demand from the asthma segment is much higher than others and is likely to remain so over the next few years, thanks to the robust pipeline of drugs for the treatment of asthma.

Some the key players operating in the global market for pulmonary drug delivery devices are Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline Plc, AstraZeneca Plc, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., MannKind Corp., Bristol-Myers Squibb Co., Mylan N.V., Omron Corp., F. Hoffmann-La Roche Ltd., 3M Healthcare, Sunovion Pharmaceuticals Inc., Koninklijke Philips N.V., Gerresheimer AG, Bespak, AptarGroup Inc., SHL Group, Nypro Healthcare Inc., Hovione, and Chiesi Farmaceutici S.p.A.

1.Preface
    1.1.Report Scope
    1.2.Market Segmentation 
    1.3.Research Highlights

2.Assumptions and Research Methodology
    2.1.Assumptions
    2.2.Research Methodology

3.Executive Summary

4.Market Overview
    4.1.Product Type Overview
    4.2.Key Industry Events
    4.3.Market Opportunity Map

5.Market Dynamics
    5.1.Drivers and Restraints Snapshot Analysis
    5.2.Drivers
    5.3.Restraints
    5.4.Opportunity Analysis
    5.5.Opportunities
    5.6.Trends
    5.7.Porter’s Five Forces Analysis
    5.8.Value Chain Snapshot

6.Pulmonary Drugs Market Analysis, by Product Type
    6.1.Key Findings
    6.2.Introduction
    6.3.Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type
    6.4.Global Pulmonary Drug Delivery Devices Market Forecast, by Product Type
          6.4.1.Global Dry Powder Inhalers (DPIs) Market Revenue (US$ Mn) and Volume (million units), 2014–2024
          6.4.2.Global Metered Dose Inhalers (MDIs) Market Revenue (US$ Mn) and Volume (million units), 2014–2024
          6.4.3.Global Nebulizers Market Revenue (US$ Mn) and Volume (million units), 2014–2024
    6.5.Global Pulmonary Drugs Market Attractiveness Analysis, by Product Type
    6.6.Key Trends

7.Pulmonary Drug Delivery Devices Market Analysis, by Application
    7.1.Key Findings
    7.2.Introduction
    7.3.Global Pulmonary Drug Delivery Devices Market Value Share Analysis, By Application, 2016 and 2024
    7.4.Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and volume (million units) Forecast, By Application, 2014–2024
          7.4.1.Global Asthma Market Revenue (US$ Mn) and volume (million units), 2014–2024
          7.4.2.Global COPD Market Revenue (US$ Mn) and volume (million units), 2014–2024
          7.4.3.Global Cystic Fibrosis Market Revenue (US$ Mn) and volume (million units), 2014–2024
          7.4.4.Global Other Applications Market Revenue (US$ Mn) and volume (million units), 2014–2024
          7.4.5.Global Pulmonary Drug Delivery Devices Market Attractiveness By Application
    7.5.Key Trends

8.Pulmonary Drug Delivery Devices Market Analysis, by Distribution Channel
    8.1.Key Findings
    8.2.Introduction
    8.3.Global Pulmonary Drug Delivery Devices Market Value Share Analysis, By Distribution Channel, 2016 and 2024
    8.4.Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, By Distribution Channel, 2015–2024
          8.4.1.Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (million units), 2014–2024
          8.4.2.Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (million units), 2014–2024
          8.4.3.Global E-commerce Market Revenue (US$ Mn) and Volume (million units), 2014–2024
    8.5.Global Pulmonary Drug Delivery Devices Market Attractiveness by Distribution Channel

9.Pulmonary Drug Delivery Devices Market Analysis, By Region
    9.1.Global Scenario
    9.2.Global Pulmonary Drug Delivery Devices Market Value Share Analysis By Region, 2016 and 2024
    9.3.Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, By Region, 2016–2024
    9.4.Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region

10.North America Pulmonary Drug Delivery Devices Market Analysis
    10.1.Key Findings
    10.2.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
    10.3. North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
    10.4.North America Market Attractiveness Analysis, by Country
    10.5.North America Market Value Share Analysis, by Product Type, 2016 and 2024
    10.6.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
    10.7.North America Market Value Share Analysis, by Application, 2016 and 2024
    10.8.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
    10.9.North America Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
    10.10.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
    10.11.North America Market Value Share Analysis, by Country, 2016 and 2024
    10.12.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
    10.13.North America Market Attractiveness Analysis, by Product Type
    10.14.North America Market Attractiveness Analysis, by Application
    10.15.North America Market Attractiveness Analysis, by Distribution Channel

11.Europe Pulmonary Drug Delivery Devices Market Analysis
    11.1.Key Findings
    11.2.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
    11.3. Europe Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
    11.4.Europe Market Attractiveness Analysis, by Country
    11.5.Europe Market Value Share Analysis, by Product Type, 2016 and 2024
    11.6.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
    11.7.Europe Market Value Share Analysis, by Application, 2016 and 2024
    11.8.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
    11.9.Europe Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
    11.10.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
    11.11.Europe Market Value Share Analysis, by Country, 2016 and 2024
    11.12.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
    11.13.Europe Market Attractiveness Analysis, by Product Type
    11.14.Europe Market Attractiveness Analysis, by Application
    11.15.Europe Market Attractiveness Analysis, by Distribution Channel

12.Asia Pacific Pulmonary Drug Delivery Devices Market Analysis
    12.1.Key Findings
    12.2.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
    12.3. Asia Pacific Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
    12.4.Asia Pacific Market Attractiveness Analysis, by Country
    12.5.Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
    12.6.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
    12.7.Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
    12.8.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
    12.9.Asia Pacific Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
    12.10.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
    12.11.Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
    12.12.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
    12.13.Asia Pacific Market Attractiveness Analysis, by Product Type
    12.14.Asia Pacific Market Attractiveness Analysis, by Application
    12.15.Asia Pacific Market Attractiveness Analysis, by Distribution Channel

13.Latin America Pulmonary Drug Delivery Devices Market Analysis
    13.1.Key Findings
    13.2.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
    13.3. Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
    13.4.Latin America Market Attractiveness Analysis, by Country
    13.5.Latin America Market Value Share Analysis, by Product Type, 2016 and 2024
    13.6.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
    13.7.Latin America Market Value Share Analysis, by Application, 2016 and 2024
    13.8.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
    13.9.Latin America Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
    13.10.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
    13.11.Latin America Market Value Share Analysis, by Country, 2016 and 2024
    13.12.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
    13.13.Latin America Market Attractiveness Analysis, by Product Type
    13.14.Latin America Market Attractiveness Analysis, by Application
    13.15.Latin America Market Attractiveness Analysis, by Distribution Channel

14.Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis
    14.1.Key Findings
    14.2.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
    14.3. Middle East & Africa Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
    14.4.Middle East & Africa Market Attractiveness Analysis, by Country
    14.5.Middle East & Africa Market Value Share Analysis, by Product Type, 2016 and 2024
    14.6.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
    14.7.Middle East & Africa Market Value Share Analysis, by Application, 2016 and 2024
    14.8.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
    14.9.Middle East & Africa Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
    14.10.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
    14.11.Middle East & Africa Market Value Share Analysis, by Country, 2016 and 2024
    14.12.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
    14.13.Middle East & Africa Market Attractiveness Analysis, by Product Type
    14.14.Middle East & Africa Market Attractiveness Analysis, by Application
    14.15.Middle East & Africa Market Attractiveness Analysis, by Distribution Channel

15.Competition Landscape
    15.1.Global Pulmonary Drugs Market Share Analysis, By Company, (2015)
    15.2.Competitive Dashboard
    15.3.Pipeline Snapshot

16.Company Profiles
    16.1.Boehringer Ingelheim GmbH 
          16.1.1.Company Overview
          16.1.2.Business Overview
          16.1.3.Financial Overview
          16.1.4.SWOT Analysis
          16.1.5.Strategic Overview
    16.2.Novartis AG 
          16.2.1.Company Overview
          16.2.2.Business Overview
          16.2.3.Financial Overview
          16.2.4.SWOT Analysis
          16.2.5.Strategic Overview
    16.3.GlaxoSmithKline plc 
          16.3.1.Company Overview
          16.3.2.Business Overview
          16.3.3.Financial Overview
          16.3.4.SWOT Analysis
          16.3.5.Strategic Overview
    16.4.AstraZeneca plc
          16.4.1.Company Overview
          16.4.2.Business Overview
          16.4.3.Financial Overview
          16.4.4.SWOT Analysis
          16.4.5.Strategic Overview
    16.5.Teva Pharmaceutical Industries Ltd. 
          16.5.1.Company Overview
          16.5.2.Business Overview
          16.5.3.Financial Overview
          16.5.4.SWOT Analysis
          16.5.5.Strategic Overview
    16.6.Merck & Co., Inc. 
          16.6.1.Company Overview
          16.6.2.Business Overview
          16.6.3.Financial Overview
          16.6.4.SWOT Analysis
          16.6.5.Strategic Overview
    16.7.MannKind Corporation 
          16.7.1.Company Overview
          16.7.2.Business Overview
          16.7.3.Financial Overview
          16.7.4.SWOT Analysis
          16.7.5.Strategic Overview
    16.8.F. Hoffmann-La Roche Ltd. 
          16.8.1.Company Overview
          16.8.2.Business Overview
          16.8.3.Financial Overview
          16.8.4.SWOT Analysis
          16.8.5.Strategic Overview
    16.9.Bristol-Myers Squibb Company
          16.9.1.Company Overview
          16.9.2.Business Overview
          16.9.3.Financial Overview
          16.9.4.SWOT Analysis
          16.9.5.Strategic Overview
    16.10.Mylan N.V. 
          16.10.1. Company Overview
          16.10.2. Business Overview
          16.10.3. Financial Overview
          16.10.4. SWOT Analysis
          16.10.5. Strategic Overview
    16.11.Omron Corporation
          16.11.1.Company Overview
          16.11.2.Business Overview
          16.11.3.Financial Overview
          16.11.4.SWOT Analysis
          16.11.5.Strategic Overview
    16.12.3M Healthcare 
          16.12.1.Company Overview
          16.12.2.Business Overview
          16.12.3.Financial Overview
          16.12.4.SWOT Analysis
          16.12.5.Strategic Overview
    16.13.Sunovion Pharmaceuticals, Inc. 
          16.13.1.Company Overview
          16.13.2.Business Overview
          16.13.3.Financial Overview
          16.13.4.SWOT Analysis
          16.13.5.Strategic Overview
    16.14.Koninklijke Philips N.V. 
          16.14.1.Company Overview
          16.14.2.Business Overview
          16.14.3.Financial Overview
          16.14.4.SWOT Analysis
          16.14.5.Strategic Overview
    16.15.Gerresheimer AG 
          16.15.1.Company Overview
          16.15.2.Business Overview
          16.15.3.Financial Overview
          16.15.4.SWOT Analysis
          16.15.5.Strategic Overview
    16.16.Bespak 
          16.16.1.Company Overview
          16.16.2.Business Overview
          16.16.3.Financial Overview
          16.16.4.SWOT Analysis
          16.16.5.Strategic Overview
    16.17.AptarGroup, Inc. 
          16.17.1.Company Overview
          16.17.2.Business Overview
          16.17.3.Financial Overview
          16.17.4.SWOT Analysis
          16.17.5.Strategic Overview
    16.18.SHL Group 
          16.18.1. Company Overview
          16.18.2. Business Overview
          16.18.3. SWOT Analysis
          16.18.4. Strategic Overview
    16.19.Nypro Healthcare Inc. (Jabil Circuit Inc.) 
          16.19.1.Company Overview
          16.19.2.Business Overview
          16.19.3.Financial Overview
          16.19.4.SWOT Analysis
          16.19.5.Strategic Overview
    16.20.Hovione 
          16.20.1.Company Overview
          16.20.2.Business Overview
          16.20.3.Financial Overview
          16.20.4.SWOT Analysis
          16.20.5.Strategic Overview
    16.21.Chiesi Farmaceutici S.p.A. 
          16.21.1.Company Overview
          16.21.2.Business Overview
          16.21.3.Financial Overview
          16.21.4.SWOT Analysis
          16.21.5.Strategic Overview

List of Figures

Figure 01: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 02: Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 03: Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 04: Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2015–2024
Figure 05: Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 06: Global Nebulizers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2015–2024
Figure 07: Global Nebulizers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 08: Global Single Dose Inhaler Market Volume and Y-o-Y Growth (%), 2015–2024
Figure 09: Global Multi Dose Inhaler Market Volume and Y-o-Y Growth (%), 2014–2024
Figure 10: Global Manually-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2015–2024
Figure 11: Global Breath-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2014–2024
Figure 12: Global Jet Nebulizers Market Volume and Y-o-Y Growth (%), 2015–2024
Figure 13: Global Ultrasonic Wave Nebulizers Market Volume and Y-o-Y Growth (%), 2014–2024
Figure 14: Global Vibrating Mesh Nebulizers Market Volume and Y-o-Y Growth (%), 2014–2024
Figure 15: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type
Figure 16: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2016 and 2024
Figure 17: Global Asthma Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 18: Asthma Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 19: Global COPD Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 20: COPD Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 21: Global Cystic Fibrosis Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 22: Cystic Fibrosis Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 23: Global Others Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 24: Others Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 25: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
Figure 26: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 27: Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 28: Retail Pharmacies Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 29: Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 31: Global E-commerce Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 32: E-commerce Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 33: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
Figure 34: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2016 and 2024
Figure 35: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region
Figure 36: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
Figure 37: North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 38: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country
Figure 39: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product, 2016 and 2024
Figure 40: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2016 and 2024
Figure 41: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 42: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
Figure 43: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product
Figure 44: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
Figure 45: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
Figure 46: Europe Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
Figure 47: Europe Pulmonary drug delivery devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 48: Europe Pulmonary drug delivery devices Market Attractiveness Analysis, by Country
Figure 49: Europe Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 50: Europe Market Value Share Analysis, by Application, 2016 and 2024
Figure 51: Europe Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 52: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
Figure 53: Europe Market Attractiveness Analysis, by Product Type 
Figure 54: Europe Market Attractiveness Analysis, by Application
Figure 55: Europe Market Attractiveness Analysis, by Distribution Channel
Figure 56: Asia Pacific Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
Figure 57: Asia Pacific Pulmonary drug delivery devices Market Y-o-Y Analysis, by Country
Figure 58: Asia Pacific Market Attractiveness Analysis, by Country
Figure 59: Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 60: Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
Figure 61: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 62: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
Figure 63: Asia Pacific Market Attractiveness Analysis, by Product Type 
Figure 64: Asia Pacific Market Attractiveness Analysis, by Application
Figure 65: Asia Pacific Market Attractiveness Analysis, by Distribution Channel
Figure 66: Latin Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million units) Forecast, 2016–2024
Figure 67: Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 68: Latin America Market Attractiveness Analysis, by Country
Figure 69: Latin America Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 70: Latin America Market Value Share Analysis, by Application, 2016 and 2024
Figure 71: Latin America Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 72: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 73: Latin America Market Attractiveness Analysis, by Product Type 
Figure 74: Latin America Market Attractiveness Analysis, by Application
Figure 75: Latin America Market Attractiveness Analysis, by Distribution Channel
Figure 76: MEA Market Size Value (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
Figure 77: MEA Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 78: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 79: Middle East & Africa Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 80: Middle East & Africa Market Value Share Analysis, by Application, 2016 and 2024
Figure 81: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 82: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
Figure 83: Middle East & Africa Market Attractiveness Analysis, by Product Type 
Figure 84: Middle East & Africa Market Attractiveness Analysis, by Application
Figure 85: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel
Figure 86: Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company (2015)

List of Tables

Table 01: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product Type, 2016–2024
Table 02: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler), 2016–2024
Table 03: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler), 2016–2024
Table 04: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer), 2016–2024
Table 05: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 06: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2014–2024
Table 07: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Region, 2016–2024
Table 08: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 09: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Dry Powder Inhalers (Product) 2016–2024
Table 10: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Metered Dose Inhalers (Product) 2016–2024
Table 11: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Nebulizers (Product) 2016–2024
Table 12: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 13: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel 2016–2024
Table 14: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2016–2024
Table 15: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 16: Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
Table 17: Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
Table 18: Europe Pulmonary Drug Delivery Devices and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
Table 19: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 20: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
Table 21: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016–2024
Table 22: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 23: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
Table 24: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
Table 25: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
Table 26: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 27: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
Table 28: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016–2024
Table 29: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 30: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
Table 31: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
Table 32: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
Table 33: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 34: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
Table 35: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2016–2024
Table 36: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 37: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
Table 38: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
Table 39: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
Table 40: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 41: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
Table 42: Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016–2024

Global Pulmonary Drug Delivery Devices Market: Overview

This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.

This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global pulmonary drug delivery devices market with respect to the leading market segments based on major products, key applications, distribution channels, and geographies.

Global Pulmonary Drug Delivery Devices Market: Segmentation

The global pulmonary drug delivery devices market has been studied based on major product type, application segments, major distribution channels, and regional as well as national markets. Based on product type, the global market has been categorized into three major segments: Dry Powder Inhalers, Metered Dose Inhalers and Nebulizers. Based on application, the global market has been categorized into four segments: Asthma, COPD, cystic fibrosis, and others. Based on distribution channels, the global market has been categorized into three key segments: retail pharmacies, hospital pharmacies, and e-commerce.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global pulmonary drug delivery devices market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products / applications / distribution channels / geographies.

Global Pulmonary Drug Delivery Devices Market: Regional Overview

Geographically, the pulmonary drug delivery devices market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). Each regional market for pulmonary drug delivery devices market has been further categorized into major product, application, and end-user segments considered within the scope of the study.

Key country (U.S., Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

Global Pulmonary Drug Delivery Devices Market: Competitive Outlook

The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the pulmonary drug delivery devices market report. The section also includes competition matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global pulmonary drug delivery devices market.

The report also profiles key players operating in the pulmonary drug delivery devices market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include AstraZeneca plc, Novartis AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Merck & Co., Inc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, 3M Healthcare, Omron Corporation, and others.

The global pulmonary drug delivery devices market has been segmented as follows:

By Product type

  • Dry Powder Inhalers
    • Single-dose inhalers
    • Multi-dose inhalers
  • Metered Dose Inhalers
    • Manually-actuated pressurized inhaler
    • Breath-actuated pressurized inhaler
  • Nebulizers
    • Jet nebulizers
    • Ultrasonic wave nebulizers
    • Vibrating mesh nebulizers

By Application

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Others

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • E-commerce

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top